Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
Follow SYK
Stryker Corporation (SYK) Return on equity
Stryker Corporation's return on equity over the twelve months to 30 June 2026 was 16.5%, up 1.4 percentage points from fiscal 2025 (15.1%). Over the past ten years it has ranged from 10.5% (fiscal 2017) to 32.7% (fiscal 2018); the current reading is higher than 45% of that period. That is above the Medical Devices industry median of −15.3% and above the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 15.1% | (0.18) |
| FY2024 | 15.3% | (2.72) |
| FY2023 | 18.0% | 3.01 |
| FY2022 | 15.0% | 0.71 |
| FY2021 | 14.3% | 1.91 |
| FY2020 | 12.4% | (4.63) |
| FY2019 | 17.0% | (15.75) |
| FY2018 | 32.7% | 22.28 |
| FY2017 | 10.5% | (7.79) |
| FY2016 | 18.2% | 1.42 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| DXCM DexCom, Inc. compare | 38.5% |
| GEHC GE HealthCare Technologies Inc. compare | 19.2% |
| SYK Stryker Corporation | 16.5% |
| BSX Boston Scientific Corporation compare | 15.4% |
| STE STERIS plc compare | 11.4% |
| ABT Abbott Laboratories compare | 10.6% |
| MDT Medtronic PLC compare | 10.6% |
| PHG Koninklijke Philips N.V. compare | 10.2% |
| EW Edwards Lifesciences Corporation compare | 9.42% |
| Medical Devices industry median | −15.3% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on SYK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement